Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug ; volume:14 ; number:1 ; day:21 ; month:5 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (21.5.2024), 1-10, 12.2024

Creator: Akhavein, Nima
Baum, Marc M.
Gunawardana, Manjula
Moss, John A.
Calvez, Sandrine
Remedios-Chan, Mariana
Fanter, Rob
Lenhard, Steve
Rusk, Samantha
Azzarano, Leonard
McCoy, Deborah
Jucker, Beat
Johns, Brian
Burke, Matt
Velthuisen, Emile

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-024-58583-w

URN: urn:nbn:de:101:1-2407311021432.437409284988

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Akhavein, Nima
Baum, Marc M.
Gunawardana, Manjula
Moss, John A.
Calvez, Sandrine
Remedios-Chan, Mariana
Fanter, Rob
Lenhard, Steve
Rusk, Samantha
Azzarano, Leonard
McCoy, Deborah
Jucker, Beat
Johns, Brian
Burke, Matt
Velthuisen, Emile
SpringerLink (Online service)

Other Objects (12)

Long-Acting Reversible Contraception

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Development of long-acting ARV’s

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda

Creation of a long-acting nanoformulated dolutegravir

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies

Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya

Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting

Long-Acting Reversible Contraception

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Development of long-acting ARV’s

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda

Creation of a long-acting nanoformulated dolutegravir

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies

Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya

Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting

Long-Acting Reversible Contraception

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Development of long-acting ARV’s

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda

Creation of a long-acting nanoformulated dolutegravir

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies

Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya

Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Long-Acting Reversible Contraception

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Development of long-acting ARV’s

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda

Creation of a long-acting nanoformulated dolutegravir

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies

Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya

Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting

Long-Acting Reversible Contraception

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Development of long-acting ARV’s

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda

Creation of a long-acting nanoformulated dolutegravir

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies

Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya

Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting

Long-Acting Reversible Contraception

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Development of long-acting ARV’s

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda

Creation of a long-acting nanoformulated dolutegravir

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages

Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies

Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya

Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting

Related objects

Reset password